Fact CheckerSign in

NCT05779969Completed

Comparison of CT Scan Between Patients With Axial Spondyloarthritis and Control Subjects

Comparison of CT Scan Aspects of the Manubriosternal Joint Between Patients With Axial Spondyloarthritis and Control Subjects

Source: ClinicalTrials.gov · Last updated 31 Dec 2024

Brief summary (registry, in English)

The aim of this study is to define structural damage to the manubriosternal joint (MST) in axial spondyloarthritis (axSpA) by comparing its CT scan aspects between a population of patients with radiographic (axSpA) and a control population free of chronic inflammatory rheumatism.

Status (registry)
Completed
Study type
Observational
Enrollment
377 (actual)
First submitted
7 Mar 2023
Start date
9 Feb 2023
Primary completion date
13 Dec 2024
Lead sponsor
Hôpital NOVO
NCT number
NCT05779969

What you commit to

  • Study type: Observational
  • Participants enrolled: 377
  • From 9 Feb 2023 to the primary completion date, 13 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Lung cancer or suspected lung cancer
  • Any of the following conditions: spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, SAPHO syndrome, chest wall bone disease, tumour bone disease, severe scoliosis, malformative syndrome
  • History of thoracic trauma or thoracic surgery,

Other

  • axSpA population:
  • Peripheral spondyloarthritis,
  • Unavailability of chest CT scan images in the hospital computer system,
  • Unknown result of pelvic X-ray.
    • Control population:
  • Unavailability of chest CT scan images in the hospital computer system.

Who the study is looking for

  • axSpA population:
  • Adults aged 18 to 69 years,
  • Diagnosis of axSpA according to the ASAS 2009 criteria,
  • Hospitalized in the Rheumatology Department of the NOVO Hospital (Pontoise site) from 01/01/2015 to 30/10/2022 and had a Chest CT scan with images available in the hospital's computer system,
  • Informed of the study and did not object.
    • Control population:
  • Adults aged 18 to 69 years,
  • Day hospitalization in the pneumology department of the NOVO Hospital (Pontoise site) from 01/01/2015 to 30/10/2022 and having had a lung scan on this occasion,
  • Informed of the study and did not object.

Age in the registry: 18 years to 69 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rheumatology department - NOVO Hospital - Pontoise site
Coordinator of this site? Confirm its status
PontoiseFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.